Exchange: OTC Sector: Healthcare Industry: Medical Devices
2.16% $106.24
America/New_York / 3 mai 2024 @ 15:55
FUNDAMENTALS | |
---|---|
MarketCap: | 13 917 mill |
EPS: | 1.740 |
P/E: | 61.06 |
Earnings Date: | Feb 18, 2024 |
SharesOutstanding: | 130.99 mill |
Avg Daily Volume: | 0.0036 mill |
RATING 2024-05-03 |
---|
A+ |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Buy | |
DE: | Neutral | |
P/E: | Neutral | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/21 | 4/21 | 2/22 | 4/22 | 2/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
2.10x |
Company: PE 61.06 | sector: PE 29.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
1.59x |
Company: PE 61.06 | industry: PE 38.34 |
DISCOUNTED CASH FLOW VALUE |
---|
$45.78 (-56.91%) $-60.46 |
Date: 2024-05-05 |
Expected Trading Range (DAY) |
---|
$ 104.26 - 108.22 ( +/- 1.86%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 |
Volume Signals | |
---|---|
Price | $106.24 (2.16% ) |
Volume | 0.0020 mill |
Avg. Vol. | 0.0036 mill |
% of Avg. Vol | 56.33 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Cochlear Limited provides implantable hearing solutions for adults and children worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.